ZVRA
Zevra Therapeutics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +7.5% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 73 | +6 | 29.05M | $415.89M | +12 | −6 |
| Q1 2026 | 69 | 0 | 26.10M | $242.75M | +4 | −4 |
| Q4 2025 | 68 | +1 | 25.36M | $227.23M | +1 | — |
| Q3 2025 | 16 | +2 | 19.14M | $181.99M | +2 | — |
| Q2 2025 | 11 | 0 | 17.09M | $150.53M | — | — |
| Q1 2025 | 8 | 0 | 6.58M | $49.25M | +1 | −1 |
| Q4 2024 | 8 | +1 | 6.30M | $52.58M | +2 | −1 |
| Q3 2024 | 6 | +2 | 1.92M | $13.36M | +3 | −1 |
| Q2 2024 | 4 | — | 1.15M | $5.62M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 4.17M | +15.2% | $36.72M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 4.08M | — | $35.96M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (pasivo) | 2.95M | — | $26.01M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (pasivo) | 2.95M | — | $26.01M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (pasivo) | 2.95M | — | $26.01M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 2.29M | — | $20.17M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 2.29M | — | $20.17M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 2.29M | — | $20.17M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Geode Capital Management ✦ (pasivo) | 1.24M | +0.8% | $10.95M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | Geode Capital Management ✦ (pasivo) | 1.24M | +0.8% | $10.95M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | State Street Global Advisors ✦ (pasivo) | 1.24M | +5.5% | $10.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Millennium Management ✦ | 634.82K | +484.0% | $5.59M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 189.31K | +591.7% | $1.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 189.31K | +591.7% | $1.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Wellington Management ✦ | 146.28K | +4.2% | $1.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Wellington Management ✦ | 146.28K | +4.2% | $1.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | Wellington Management ✦ | 146.28K | +4.2% | $1.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 114.27K | -54.1% | $1.01M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | Citadel Advisors ✦ | 114.27K | -54.1% | $1.01M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 25.69K | +13.2% | $227,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 147 tenedores, 40.93M acciones, $378.34M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.